Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
GHRS GH Research PLC
- Stocks
- Healthcare
- NASDAQ: GHRS
Price (delayed)
$10.98
Market cap
$681.07M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.79
Enterprise value
$436.77M
gh research is a privately-held clinical-stage biopharmaceutical company developing novel therapies for the management of mental illness.
Highlights
The quick ratio has soared by 76% QoQ and by 35% YoY
GH Research's equity has surged by 73% QoQ and by 48% YoY
GH Research's debt has decreased by 27% YoY but it has increased by 5% QoQ
GH Research's net income has decreased by 30% YoY and by 8% from the previous quarter
GHRS's EPS is down by 27% year-on-year and by 5% since the previous quarter
Key stats
What are the main financial stats of GHRS
Market
Valuations
Earnings
Shares outstanding
62.03M
Market cap
$681.07M
Enterprise value
$436.77M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.84
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$51.52M
Net income
-$42.11M
EBIT
-$41.39M
EBITDA
-$41.08M
Free cash flow
-$48.87M
Per share
Balance sheet
Liquidity
EPS
-$0.79
EPS diluted
-$0.79
Free cash flow per share
-$0.94
Book value per share
$5.96
Revenue per share
$0
TBVPS
$6.16
Total assets
$320.45M
Total liabilities
$10.24M
Debt
$658,000
Equity
$310.21M
Working capital
$284.75M
Debt to equity
0
Current ratio
29.71
Quick ratio
29.38
Net debt/EBITDA
5.95
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-18.4%
Return on equity
-19.2%
Return on invested capital
-46.2%
Return on capital employed
-13.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GHRS stock price
How has the GH Research stock price performed over time
Intraday
2.62%
1 week
5.78%
1 month
26.21%
1 year
-13.75%
YTD
56.86%
QTD
-0.45%
Financial performance
How have GH Research's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$51.52M
Net income
-$42.11M
Gross margin
N/A
Net margin
N/A
GH Research's net income has decreased by 30% YoY and by 8% from the previous quarter
GH Research's operating income has decreased by 22% YoY and by 2.4% from the previous quarter
Price vs fundamentals
How does GHRS's price correlate with its fundamentals
Growth
What is GH Research's growth rate over time
Valuation
What is GH Research stock price valuation
P/E
N/A
P/B
1.84
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GHRS's EPS is down by 27% year-on-year and by 5% since the previous quarter
GH Research's equity has surged by 73% QoQ and by 48% YoY
The price to book (P/B) is 29% less than the 5-year quarterly average of 2.6 and 16% less than the last 4 quarters average of 2.2
Efficiency
How efficient is GH Research business performance
GHRS's return on invested capital has dropped by 103% year-on-year and by 29% since the previous quarter
GHRS's return on equity is down by 32% year-on-year but it is up by 4.5% since the previous quarter
The return on assets has declined by 30% year-on-year but it is up by 4.2% since the previous quarter
Dividends
What is GHRS's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GHRS.
Financial health
How did GH Research financials performed over time
The quick ratio has soared by 76% QoQ and by 35% YoY
GHRS's current ratio has surged by 72% since the previous quarter and by 35% year-on-year
GH Research's debt is 100% lower than its equity
GH Research's equity has surged by 73% QoQ and by 48% YoY
GH Research's debt has decreased by 27% YoY but it has increased by 5% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.